1Querfurth HW,LaFerla FM. Alzheimer's disease[J].{H}New England Journal of Medicine,2010.329-344.
2Zhang ZX,Zahner GE,Román GC. Dementia subtypes in China:prevalence in Beijing,Xian,Shanghai,and Chengdu[J].{H}Archives of Neurology,2005.44.7-4453.
3Perl DP. Neuropathology of Alzheimer's disease[J].{H}Mount Sinai Journal of Medicine,2010.32-42.
4Eckenhoff RG,Johansson JS,Wei H. Inhaled anesthetic enhancement ofamyloid-β3oligomerization and cytotoxicity[J].{H}ANESTHESIOLOGY,2004.703-709.
5Planel E,Krishnamurthy P,Miyasaka T. Anesthesia-induced hyperphosphorylation detaches 3-repeat tau from microtubules without affecting their stability in vivo[J].{H}Journal of Neuroscience,2008.12798-12807.
6Xie Z,Dong Y,Maeda U. The common inhalation anesthetic isoflurane induces apoptosis and increases amyloid β protein levels[J].{H}ANESTHESIOLOGY,2006.988-994.
7Dong Y,Zhang G,Zhang B. The common inhalational anesthetic sevoflurane induces apoptosis and increases β-amyloid protein levels[J].{H}Archives of Neurology,2009.620-631.
8Zhen Y,Dong Y,Wu X. Nitrous oxide plus isoflurane induces apoptosis and increases β-amyloid protein levels[J].{H}ANESTHESIOLOGY,2009.741-752.
9Planel E,Bretteville A,Liu L. Acceleration and persistence of neurofibrillary pathology in a mouse model of tauopathy following anesthesia[J].{H}FASEB JOURNAL,2009.2595-2604.
10Le Freche H,Brouillette J,Femandez-Gomez FJ. Tau phosphorylation and sevoflurane anesthesia:an association to postoperative cognitive impairment[J].{H}ANESTHESIOLOGY,2012.779-787.
4Wenk GL, Pierce DJ, Struble R, et al. Age-related changes in multiple neurotransmitters systems in the monkey brain. Neurobiol Aging, 1989,10 : 11-19.
5Lars Backman, Lars Nyberg, Ulman Lindenberger, et al. The correlative triad among aging, dopamine, and cognition : current status and future prospects . Neuros Biobeh Rev, 2006, 30 : 791- 807.
6Li SC, Ulman Lindenberger, Sverker Sikstom. Aging cognition: from neuromodulation to representation. Trends Cognit Sci, 2001, 5 : 479-486.
8Bartus RT. On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis. Exp Neurobiol, 2000, 163: 495 -529.
9Lazaris A, Bertrand F, Lazarus C, et al. Baseline and 8-OHDPAT-indnced release of acetylcholine in the hippocampus of aged rats with different levels of cognitive dysfunction. Brain Res, 2003, 967:181-190.
10Tottori K, Nakai M, Uwahodo Y, et al. Attenuation of scopolamine-induced and age-associated memory impairments by the sigma and 5-hydroxytryptamine (1 A ) receptor agonist OPC- 14523 ( 1-[ 3-[ 4-( 3-chlorophenyl )-1-piperazinyl propyl ]-5- methoxy-3, 4-dihydro-2 [ 1 H ] -quinolinone monomethanesulfonate). J Pharmacol Exp Ther, 2002, 301 : 249- 257.
